Health technology brand Hilo, developed by Aktiia, has launched its Hilo Core blood pressure monitoring system in the US.

Following TYBR’s B3 GEL’s US launch in January 2026, the company primarily intends to use the funds to expand market access to the hydrogel.

Cardinal Health’s acquisitions of Strive Medical and Adapt Health’s diabetes unit are collectively intended to support its at-home care business’s growth strategy.

Fresenius Medical Care has introduced TherapyWise, a cloud-based analytics platform aimed at supporting hospital and critical care teams overseeing KRT in the US.

GE HealthCare's tool is intended to streamline imaging workflow collaboration between different specialist teams in areas such as oncology.

British Business Bank has previously co-invested in EQT's fund portfolio companies Phagenesis and Cyted Health.

GE HealthCare and Catholic Health have signed a 10-year strategic alliance valued at around $500m, aimed at expanding access to precision diagnostics, advanced imaging, and AI-supported technology ...

RapidPulse has secured $48m to advance the clinical development of its aspiration technology to treat acute ischaemic stroke.

Neko Health has raised $700m, setting the company up with proceeds to scale its full-body scanning service ahead of the planned launch of its first US clinics this year. Putting its funds raised to ...

Neuraptive Therapeutics has secured an exclusive licence from Washington University in St. Louis for a bioresorbable wireless electronic stimulation device designed for peripheral nerve repair.

Resmed’s decision to sell MatrixCare to PE firm Frazier Healthcare Partners comes less than a decade after its $750m acquisition of the software business.

HistoSonics will now initiate a phased commercial rollout of its Edison system across European centres of excellence that specialise in liver tumour treatment.